Pallawi Torka

32PUBLICATIONS
296CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersImmunogenetics (incl. genetic immunology)Immunology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Sep 27, 2026
Real-world outcomes of nivolumab-AVD and brentuximab vedotin-AVD in paediatric and adult advanced-stage Hodgkin lymphoma.

|Aug 07, 2026
Racial/ethnic disparities in risk of second primary malignancies among Diffuse Large B-cell Lymphoma survivors.

|Jul 10, 2026
Clinical outcomes, patterns of relapse, and molecular landscape of advanced stage high-grade B-cell lymphoma.

|Jun 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKs.

|Apr 29, 2026
Integrative Molecular Analysis Reveals Determinants of Clinical Outcomes in TP53-Mutated Diffuse Large B-Cell Lymphoma.

|Apr 14, 2026
Historical outcomes for patients with stage IA NLPHL: Global NLPHL One Working Group retrospective analyses.

Jamie E Flerlage, Dennis A Eichenauer, Michael Fuchs

Pageof 6

Frequent Collaborators

12 joint publications

Narendranath Epperla

9 joint publications

Reem Karmali

7 joint publications

Kevin David

5 joint publications

Geoffrey Shouse